Business Wire · ZLAB · November 13, 2026

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

Get the app for more

Explore stock news, insights and company research.